Alinidine
-
Alinidine
structure -
-
CAS No:
33178-86-8
-
Formula:
C12H13Cl2N3
-
Chemical Name:
Alinidine
-
Synonyms:
1H-Imidazol-2-amine,N-(2,6-dichlorophenyl)-4,5-dihydro-N-2-propen-1-yl-;2-Imidazoline,2-(N-allyl-2,6-dichloroanilino)-;1H-Imidazol-2-amine,N-(2,6-dichlorophenyl)-4,5-dihydro-N-2-propenyl-;N-(2,6-Dichlorophenyl)-4,5-dihydro-N-2-propen-1-yl-1H-imidazol-2-amine;St 567;Alinidine
-
CAS No:
Safety Information
22-36/37/38
26
Xn
P261, P264, P270, P271, P280, P301+P310, P302+P352, P304+P340, P305+P351+P338, P312, P321, P330, P332+P313, P337+P313, P362, P403+P233, P405, P501
H301
|Danger|H301 (100%): Toxic if swallowed [Danger Acute toxicity, oral]|P261, P264, P270, P271, P280, P301+P310, P302+P352, P304+P340, P305+P351+P338, P312, P321, P330, P332+P313, P337+P313, P362, P403+P233, P405, and P501|Aggregated GHS information provided by 38 companies from 1 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
Drug Information
Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade. (See all compounds classified as Anti-Arrhythmia Agents.)|Agents that affect the rate or intensity of cardiac contraction, blood vessel diameter, or blood volume. (See all compounds classified as Cardiovascular Agents.)
2-(N-allyl-N-(2,6-dichlorophenyl)amino)-2-imidazoline
Computed Properties
Molecular Weight:270.15
XLogP3:2.7
Hydrogen Bond Donor Count:1
Hydrogen Bond Acceptor Count:1
Rotatable Bond Count:4
Exact Mass:269.0486528
Monoisotopic Mass:269.0486528
Topological Polar Surface Area:27.6
Heavy Atom Count:17
Complexity:296
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes